Taysha Gene Therapies Inc.
TSHA | NASDAQ
$5.14
+$0.10 (+1.98%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -16.18 | -4.81 | -1.84 | -0.60 | -2.51 | -7.81 |
PEG Ratio | 2.91 | 0.08 | 0.02 | 0.03 | -0.07 | 0 |
PS Ratio | 179.93 | 51.93 | 13.30 | 39.70 | n/a | n/a |
PB Ratio | 7.12 | 6.05 | 2.74 | 104.67 | 4.60 | 1.87 |
P/FCF Ratio | -18.74 | -5.30 | -2.56 | -0.88 | -3.16 | -11.78 |
P/OCF Ratio | -18.89 | -5.33 | -2.81 | -1.12 | -3.75 | -15.26 |
OCF/S Ratio | -952.52 | -974.74 | -472.58 | -3.53K | n/a | n/a |
Debt / Equity Ratio | 0.07 | 0.88 | 0.82 | 63.15 | 0.66 | n/a |
Quick Ratio | 12.23 | 5.42 | 4.08 | 1.54 | 3.08 | 36.17 |
Current Ratio | 12.23 | 5.42 | 4.08 | 1.54 | 3.08 | 36.17 |
Asset Turnover | 0.03 | 0.05 | 0.09 | 0.02 | n/a | n/a |
Interest Coverage | -1.75K | -896.66 | -14.49 | -33.18 | -121.34 | -1.54K |
Return on Equity | -44.14% | -124.85% | -148.88% | -17.49K% | -182.97% | -17.11% |
Return on Assets | -31.75% | -55.68% | -64.59% | -131.47% | -81.57% | -16.61% |
Return on Invested Capital | -34.88% | -67.24% | -52.64% | -193.87% | -106.82% | -17.08% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 0.60% | n/a | n/a |
Net Profit Margin | -1.12K% | -1.07K% | -722.06% | -6.64K% | n/a | n/a |
Pretax Profit Margin | -1.12K% | -1.07K% | -722.06% | -6.64K% | n/a | n/a |
Operating Profit Margin | -1.13K% | -1.1K% | -468.83% | -5.04K% | n/a | n/a |
FCF Margin | -960.07% | -979.23% | -520.27% | -4.53K% | n/a | n/a |
EBITDA Margin | -1.1K% | -1.06K% | -680.84% | -6.38K% | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TSHA